financetom
Market
financetom
/
Market
/
Oil hovers below recent highs; ends week up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil hovers below recent highs; ends week up
Oct 23, 2021 12:10 AM

Oil traded just below multi-year highs on Friday with bullish sentiment about low supplies tamped by concerns from world leaders that demand disruptions from the COVID-19 pandemic may not be over.

Share Market Live

NSE

Brent crude futures rose 92 cents, or 1.1 percent, to settle at $85.53 a barrel. The benchmark, which touched a three-year high of $86.10 on Thursday, was up 1 percent in the week, its seventh weekly gain.

US West Texas Intermediate (WTI) crude futures gained $1.26, or 1.5 percent, to settle at $83.76 a barrel, not far off a seven-year high hit this week. The contract gained 1.7 percent on the week and was up for a ninth straight week.

Prices have been boosted by worries about coal and gas shortages in China, India and Europe, spurring some power generators to switch from gas to fuel oil and diesel.

Also Read | Natural gas prices fall 19% from multi-year highs in US; why and what it means for India

Winter weather in much of the United States is expected to be warmer than average, according to a National Oceanic and Atmospheric Administration forecast.

US crude found support this week as investors eyed low crude stocks at the US storage hub in Cushing, Oklahoma.

US Energy Information Administration data on Wednesday showed crude stocks at Cushing fell to 31.2 million barrels, their lowest level since October 2018.

"America's gasoline demand appears to be experiencing an Indian summer," PVM analysts said in a note, pointing to the highest implied demand for this time of year since 2007 despite high pump prices.

"Supply is still very, very tight, the market is just cautious about the possibility of an uptick in COVID cases in Russia, China and now Germany," said Phil Flynn, senior analyst at Price Futures Group in Chicago.

Prices pulled back from earlier intraday highs after German Chancellor Angela Merkel said the pandemic is not yet over.

Federal Reserve Chairman Jerome Powell said he could not rule out another COVID-19 spike this winter.

Also Read | Jerome Powell says inflation risks rising, but Fed can be 'patient'

(Edited by : Yashi Gupta)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ICICI Bank up 1%; Here's why brokerages are positive on the stock
ICICI Bank up 1%; Here's why brokerages are positive on the stock
Dec 6, 2021
Despite an upbeat commentary from analysts, ICICI Bank shares traded weak earlier on Monday. However, the stock managed to stage a recovery and was now trading above the flatline. ICICI Bank's top management and the various business heads gave a presentation over the weekend, post which several brokerage firms reiterated their positive stance for the lender's stock.
Right time to buy tech stocks; see environment of high inflation: Port Shelter Investment
Right time to buy tech stocks; see environment of high inflation: Port Shelter Investment
Dec 6, 2021
Richard Harris, Chief Executive Officer at Port Shelter Investment Management, sees an environment of high inflation and likes India for the long term. 
Tech Mahindra acquires 100% stake in Activus Connect; shares gain over 1%
Tech Mahindra acquires 100% stake in Activus Connect; shares gain over 1%
Dec 6, 2021
Tech Mahindra shares rise over one percent on Monday after the technology major announced that it has acquired a 100 percent stake in Activus Connect, for $62 million including earnouts. At 9:16 am, the technology company's stock was trading 0.8 percent higher at Rs 1,605.55 on BSE.
Eris Lifesciences stock soars 10% on tie-up with MJ Biopharm to enter insulin market
Eris Lifesciences stock soars 10% on tie-up with MJ Biopharm to enter insulin market
Dec 6, 2021
Eris Lifesciences jumped as much as 10 percent on Monday after the company said it has formed a joint venture with MJ Biopharm to enter the insulin segment. Eris Lifesciences will hold a 70 percent stake in the venture and the remaining 30 percent will be held by MJ Biopharm. The initial contracted tenure of the joint venture will be 10 years.
Copyright 2023-2026 - www.financetom.com All Rights Reserved